Lactobacillus plantarum LRCC 5273 isolated from Kimchi ameliorates diet-induced hypercholesterolemia in C57BL/6 mice

Bioscience, Biotechnology, and Biochemistry
Wan HeoYoung-Jun Kim

Abstract

This study was designed to select potent cholesterol-lowering probiotic strains on HepG2 cell and investigate the effect of selected strain, Lactobacillus plantarum LRCC 5273 and LRCC 5279 in hypercholesterolemic mice. In the results, LP5273 group showed significantly reduced total and LDL cholesterol compared to HCD group. In addition to significantly up-regulated hepatic mRNA expression of LXR-α and CYP7A1, intestinal LXR-α and ABCG5 were significantly up-regulated in LP5273 group. With activation of hepatic and intestinal LXR-α and its target genes, fecal cholesterol and bile acid excretion were increased in LP5273 fed mice. These results suggest that LP5273 ameliorates hypercholesterolemia in mice through the activation of hepatic and intestinal LXR-α, resulting in enhancement of fecal cholesterol and bile acids excretion in the small intestine. The results of present study suggest mechanistic evidences for hypocholesterolemic effects of L. plantarum spp., and may contribute to future researches for prevention of hypercholesterolemia and cardiovascular disease.

References

Sep 1, 1977·Clinica Chimica Acta; International Journal of Clinical Chemistry·J de WaelH J Endeman
Jun 1, 1992·The American Journal of Clinical Nutrition·P N Hopkins
Sep 1, 1995·The Journal of Applied Bacteriology·I De SmetW Verstraete
Feb 7, 2001·The American Journal of Clinical Nutrition·J Schrezenmeir, M de Vrese
Mar 20, 2002·The Journal of Biological Chemistry·Joyce J RepaDavid J Mangelsdorf
Jul 10, 2002·The Journal of Biological Chemistry·Torsten PlōschFolkert Kuipers
Aug 24, 2004·American Journal of Epidemiology·Melissa A AustinSteve E Humphries
Jan 18, 2006·Biochemical and Biophysical Research Communications·Caroline DuvalSophie Lestavel
Jun 27, 2006·Biochimica Et Biophysica Acta·Clara CavelierArnold von Eckardstein
Sep 28, 2006·Annual Review of Physiology·David Q-H Wang
Nov 28, 2006·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Leon A SimonsPatricia Conway
May 7, 2009·The Journal of Biological Chemistry·Jelske N van der VeenFolkert Kuipers
Oct 20, 2009·The Journal of Endocrinology·Chunyan Zhao, Karin Dahlman-Wright
Apr 23, 2010·Current Opinion in Lipidology·Astrid E van der VeldeAlbert K Groen
Jul 20, 2010·International Journal of Molecular Sciences·Lay-Gaik Ooi, Min-Tze Liong
Jan 25, 2011·Letters in Applied Microbiology·K S HanM Boland
May 23, 2012·Experimental Diabetes Research·Manoj KumarHariom Yadav
Sep 11, 2012·Journal of Clinical Biochemistry and Nutrition·Kayoko HondaNaotaka Hashizume
May 30, 2013·World Journal of Gastroenterology : WJG·Li-Xin WangJi-Kui Hao
Jul 16, 2013·Letters in Applied Microbiology·I A Machorro-MéndezH S García
Feb 28, 2014·Annals of the New York Academy of Sciences·Mary Ellen SandersBruno Pot
Oct 9, 2014·BioMed Research International·Catherine Tomaro-DuchesneauSatya Prakash

❮ Previous
Next ❯

Citations

Nov 8, 2019·Molecular Nutrition & Food Research·Victoria L O'Morain, Dipak P Ramji
May 1, 2020·Bioscience Reports·Bo ZhangChunsheng Li
Jun 6, 2020·Journal of Applied Microbiology·M F P Domingos-LopesC C G Silva
Aug 5, 2020·Applied Microbiology and Biotechnology·Se Hee LeeChe Ok Jeon
Oct 15, 2021·Probiotics and Antimicrobial Proteins·Hongsup YoonWilhelm H Holzapfel

❮ Previous
Next ❯

Methods Mentioned

BETA
protein assay
PCRs
PCR

Software Mentioned

SAS

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.